U.S. flag

An official website of the United States government

NM_000530.8(MPZ):c.278G>A (p.Gly93Glu) AND Inborn genetic diseases

Germline classification:
no classifications from unflagged records (1 submission)
Last evaluated:
Jun 19, 2024
Review status:
no classifications from unflagged records
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002436458.3

Allele description [Variation Report for NM_000530.8(MPZ):c.278G>A (p.Gly93Glu)]

NM_000530.8(MPZ):c.278G>A (p.Gly93Glu)

Gene:
MPZ:myelin protein zero [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q23.3
Genomic location:
Preferred name:
NM_000530.8(MPZ):c.278G>A (p.Gly93Glu)
HGVS:
  • NC_000001.11:g.161306878C>T
  • NG_008055.1:g.8095G>A
  • NM_000530.8:c.278G>AMANE SELECT
  • NM_001315491.2:c.278G>A
  • NP_000521.2:p.Gly93Glu
  • NP_001302420.1:p.Gly93Glu
  • LRG_256t1:c.278G>A
  • LRG_256:g.8095G>A
  • NC_000001.10:g.161276668C>T
  • NM_000530.6:c.278G>A
Protein change:
G93E
Links:
dbSNP: rs1060503418
NCBI 1000 Genomes Browser:
rs1060503418
Molecular consequence:
  • NM_000530.8:c.278G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001315491.2:c.278G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

No clinical assertions found. See "Flagged submissions" below.

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.

Numakura C, Lin C, Ikegami T, Guldberg P, Hayasaka K.

Hum Mutat. 2002 Nov;20(5):392-8.

PubMed [citation]
PMID:
12402337

Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.

Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira J, Kaji R, Oka N, Sobue G; Study Group for Hereditary Neuropathy in Japan..

Brain. 2003 Jan;126(Pt 1):134-51. Review.

PubMed [citation]
PMID:
12477701
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV002746114.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.G93E variant (also known as c.278G>A), located in coding exon 3 of the MPZ gene, results from a G to A substitution at nucleotide position 278. The glycine at codon 93 is replaced by glutamic acid, an amino acid with similar properties. This variant has been identified in multiple individuals with Charcot-Marie-Tooth disease; however, clinical details are limited (Hattori N et al. Brain, 2003 Jan;126:134-51; Numakura C et al. Hum. Mutat., 2002 Nov;20:392-8; Ikegami T et al. Am. J. Med. Genet., 1997 Aug;71:246-8). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Flagged submissions

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002746114Ambry Genetics
flagged submission
Reason: Outlier claim with insufficient supporting evidence
Notes: None

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Jul 10, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Last Updated: Sep 29, 2024